|18th November 2019
In the past year, the competition in biosimilars and complex generics has complicated the launch landscape. An abundance of discoveries coupled with radically evolving stakeholder needs is also straining the traditional pharmaceutical launch.
In this special pack, we provide a comprehensive outlook of launch excellence. We cover topics ranging from gathering effective insights, to understanding the current landscape, and the importance of pre-launch strategy for improving relationships between the customer and the brand.
The report also features interviews with key players such as organisational transformation expert Philip Atkinson. He shares his unique perspective on the importance of structuring agile organisational change to help pharmaceutical companies adapt and stay competitive.
These articles are complemented by case studies curated by our experienced in-house team.
In this publication, we help you answer the following questions:
Are you prepared for a successful launch?
How can you use insights to understand customers decision-making behaviour?
What are you missing in your CAR-T service launch?
How do you stay competitive with a lean pharmaceutical launch?
Multi-indication launches - how do you navigate in this space?
|22nd June 2020
Despite facing worse health outcomes, minority populations are often left out of clinical trials and miss the opportunity to participate in life-saving research. Associate Consultant Ling Song explores this issue and calls for the pharmaceutical industry to change its approach.
|9th June 2020
COVID-19 has drastically changed the lives of healthcare professionals. They are emotionally and physically drained and under huge amounts of pressure. They also need pharma’s help. Senior Consultant Pany Koizi outlines five principles for engaging with physicians during the pandemic.